Prominent publications by Hitoji Uchiyama

KOL Index score: 10589

PURPOSE: beta-catenin is the downstream effector of the Wnt signaling pathway, and it regulates cell proliferation. beta-catenin overexpression correlates positively with prognosis in several types of malignancies. We herein assessed its effects on growth of multiple myeloma cells using a xenograft model.

EXPERIMENTAL DESIGN: We first investigated the expression of beta-catenin in multiple myeloma cell lines and multiple myeloma cells obtained from patients. Next, we investigated the ...

Conhecido por Multiple Myeloma |  small interfering |  mouse model |  beta catenin |  inbred balb mice
KOL Index score: 8870

PURPOSE: To evaluate intraocular pressure (IOP) change through hemodialysis and examine other factors to affect IOP change in patients treated with hemodialysis.

DESIGN: Prospective, observational case series.

METHODS: IOP, blood pressure, and plasma colloid osmotic pressure (COP) were measured in 188 eyes of 95 patients receiving hemodialysis in Nantan General Hospital.

RESULTS: IOP significantly decreased after hemodialysis (P = 0.006). Body weight, systolic and diastolic blood ...

Conhecido por Intraocular Pressure |  hemodialysis patients |  renal dialysis |  iop blood |  female glaucoma
KOL Index score: 8359

In the opinion of the European LeukemiaNet (ELN), nucleophosmin member 1 gene mutation (NPM1 mut)-positive acute myeloid leukemia (AML) with an fms-like kinase 3-internal tandem duplication (FLT3-ITD) allele ratio (AR) <0.5 (low AR) has a favorable prognosis, and allogeneic hematopoietic stem cell transplant (allo-HSCT) in the first complete remission (CR1) period is not actively recommended. We studied 147 patients with FLT3-ITD gene mutation-positive AML, dividing them into those with ...

Conhecido por Prognostic Impact |  myeloid leukemia |  npm1 mutation |  allohsct cr1 |  tyrosine kinase
KOL Index score: 8172

Recently, the ligand for c-mpl has been cloned and initial studies have shown it to be the platelet regulatory factor, thrombopoietin (TPO). To elucidate the role of TPO in the reconstitution of megakaryopoiesis and platelet production after stem cell transplantation, we measured serum TPO levels in nine patients undergoing autologous peripheral blood stem cell transplantation (PBSCT) and in healthy volunteers. Serum TPO levels significantly correlated with the degree of peripheral ...

Conhecido por Stem Cell |  thrombopoietin levels |  platelet count |  autologous peripheral |  serum tpo
KOL Index score: 7777

To improve the selection of donors for allogeneic stem cell transplantation, it is important to identify reliable parameters that predict CD34+-cell yields after granulocyte-colony stimulating factor (G-CSF)-induced peripheral blood stem cell (PBSC) mobilization. We retrospectively investigated the peripheral blood (PB) kinetics of white blood cells (WBCs), CD34+ cells, matrix metalloproteinases (MMP)-9 and -2, and tissue inhibitors of metalloproteinases (TIMP)-1 and -2 in 15 healthy ...

Conhecido por Stem Cell |  peripheral blood |  stimulating factor |  granulocyte colony |  gcsf treatment
KOL Index score: 7740

Autologous hematopoietic cell transplantation (HCT) has not gained universal popularity in the treatment of acute myeloid leukemia (AML), and its status remains unclear. To determine the implementation status and outcomes of autologous HCT for adults with AML in Japan, we analyzed data from 1,174 patients (including 446 with acute promyelocytic leukemia [APL]) who underwent autologous HCT between 1992 and 2016 consecutively reported to the Japanese nationwide transplantation registry. ...

Conhecido por Acute Myeloid Leukemia |  cell transplantation |  autologous hematopoietic |  myeloid aml |  complete remission
KOL Index score: 7699

High-dose chemotherapy (HDT) supported by autologous stem cell transplantation (ASCT) has long been one of the standards of care for younger patients with multiple myeloma (MM). Cyclophosphamide (CY) plus granulocyte colony-stimulating factor (G-CSF) has been the conventional preparation for hematopoietic progenitor cell (HPC) mobilization, although the optimal dosage of CY in this setting has not yet been clearly defined. This study investigated the efficacy and safety of low-dose ...

Conhecido por Multiple Myeloma |  cell mobilization |  stimulating factor |  granulocyte colony |  patients mm
KOL Index score: 7226

Therapy-related acute myeloid leukemia and myelodysplastic syndrome (t-AML/MDS) represent severe late effects in patients receiving hematopoietic cell transplantation (HCT) for lymphoma. The choice between high-dose therapy with autologous HCT and allogeneic HCT with reduced-intensity conditioning remains controversial in patients with relapsed lymphoma. We retrospectively analyzed incidence and risk factors for the development of t-AML/MDS in lymphoma patients treated with autologous or ...

Conhecido por Myelodysplastic Syndrome |  autologous hct |  cell transplantation |  acute myeloid |  patients risk
KOL Index score: 6571

OBJECTIVE: We retrospectively investigated the efficacy and predictive factors for the treatment outcomes of bortezomib plus dexamethasone (BD) as second-line induction therapy prior to high-dose chemotherapy supported by autologous stem cell transplantation (HDT/ASCT) in multiple myeloma (MM) patients.

METHODS: Sixty-six transplant eligible MM patients treated by the Kyoto Clinical Hematology Study Group between 2006 and 2011 were investigated. Conventional induction chemotherapy, ...

Conhecido por Multiple Myeloma |  stem cell |  induction therapy |  partial response |  asct patients
KOL Index score: 6385

We conducted a multicenter prospective study for evaluating the utility and prognostic markers of recombinant human soluble thrombomodulin (rTM) treatment for acute disseminated intravascular coagulation (DIC) by various types of hematologic malignancies. The study comprised 30 patients with DIC due to hematologic diseases without severe infection. DIC improved in 15 patients and 20 were alive on day 28. Univariate analyses showed that, in comparison with patients who had survived on day ...

Conhecido por Disseminated Intravascular |  rtm dic |  adamts13 activity |  human soluble |  severe infection
KOL Index score: 6200

Subcutaneous panniculitis-like T cell lymphoma (SPTL) is a rare subtype of non-Hodgkin lymphoma for which a definitive therapeutic strategy has not been established yet. We report a case of chemotherapy-resistant SPTL with hemophagocytic syndrome (HPS) which was successfully treated with cyclosporine A (CsA) plus methylprednisolone (mPSL), and also reviewed 11 SPTL cases treated with CsA, previously reported in the literature. Our patient was a 38-year-old female with SPTL. The disease ...

Conhecido por Cell Lymphoma |  hemophagocytic syndrome |  subcutaneous panniculitis |  2 weeks |  complete remission
KOL Index score: 6106

The prognostic significance of FLT3-tyrosine kinase domain (TKD) mutations remains unknown. To investigate the prognostic impact of FLT3-TKD, 676 de novo acute myeloid leukemia (AML), we retrospectively analyzed cases and conducted a review of the literature. Of the 676 de novo AML cases, 34 (5.0%) were FLT3-TKD-positive; both FLT3-TKD and FLT3-ITD were noted in only two cases (0.3%). Although no significant differences in relapse-free survival (RFS) were noted, FLT3-TKD-positive cases ...

Conhecido por Tyrosine Kinase |  acute myeloid |  flt3 tkd |  prognostic significance |  leukemia aml
KOL Index score: 6043

INTRODUCTION: The most common cause of central pontine myelinolysis is an overly rapid correction of hyponatremia, although it can also occur in patients with any condition leading to nutritional or electrolyte stress. We report a case of diffuse large B-cell lymphoma with central pontine myelinolysis developing at the onset of disease. To the best of our knowledge, hematological malignancies presenting with central pontine myelinolysis have been rarely reported, especially in previously ...

Conhecido por Central Pontine |  cell lymphoma |  diffuse large |  resonance imaging |  brain magnetic

Pessoas importantes para Multiple Myeloma

Principais kols do mundo
Kenneth **** ********
multiple myeloma mm cells board directors
Robert * ****
multiple myeloma undetermined significance consultancy funding
Sundararajan ******* ********
multiple myeloma consultancy funding undetermined significance
Paul ****** *** **********
multiple myeloma board directors advisory committees
JesusFernando *** *** ******
multiple myeloma consultancy honoraria board directors
Bart ********
multiple myeloma total therapy gene expression

Hitoji Uchiyama:Impacto especializado

Conceitos para os quaisHitoji Uchiyamatem influência direta:Multiple myeloma,  Large bcell,  Cell lymphoma,  Prognostic impact,  Platelet engraftment,  Cell transplantation,  Diffuse large,  Myeloid leukemia.

Hitoji Uchiyama:Kol Impact

Conceitos relacionados ao trabalho de outros autores para os quaisfor which Hitoji Uchiyama tem influência:Multiple myeloma,  Acute myeloid leukemia,  Stem cell,  Intraocular pressure,  Peripheral blood,  Flt3 inhibitors,  Stimulating factor.



Este é o seu perfil? manage_accounts Reivindique seu perfil content_copy Copiar URL code Incorporar link para o seu perfil

Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; | Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan | Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan